C07D 277/54
Nitrogen and either oxygen or sulfur atoms
C07D277/54 (Nitrogen and either oxygen or sulfur atoms) appears on 240 US grants and 207 published applications in this corpus.
Search patents in C07D- Granted patents
- 240
- Published applications
- 207
- Assignees
- 147
- Inventors
- 715
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 6 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 7 | 8 |
| 2003 | 2 | 4 |
| 2004 | 6 | 15 |
| 2005 | 6 | 5 |
| 2006 | 7 | 10 |
| 2007 | 5 | 11 |
| 2008 | 10 | 15 |
| 2009 | 6 | 8 |
| 2010 | 5 | 7 |
| 2011 | 11 | 13 |
| 2012 | 12 | 9 |
| 2013 | 7 | 10 |
| 2014 | 7 | 11 |
| 2015 | 7 | 7 |
| 2016 | 11 | 6 |
| 2017 | 7 | 9 |
| 2018 | 8 | 8 |
| 2019 | 9 | 8 |
| 2020 | 7 | 6 |
| 2021 | 5 | 3 |
| 2022 | 4 | 4 |
| 2023 | 1 | 13 |
| 2024 | 5 | 5 |
| 2025 | 6 | 7 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymorphs of Ponesimod15 Sep 2026US 12,735,391 B2Tapi Czech Industries S.R.O
- Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof18 Aug 2026US 12,709,603 B2vTv Therapeutics LLC
- Deuterated aminothiazole compounds as antiviral compounds17 Feb 2026US 12,552,756 B2Innovative Molecules GmbH
- WDR5-MYC inhibitors10 Feb 2026US 12,545,649 B2Vanderbilt University
- MYC inhibitors and uses thereof10 Feb 2026US 12,545,654 B2StemSynergy Therapeutics, Inc.
- Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof30 Jul 2026US 2026/0217666 A1vTv Therapeutics LLC
- Compounds and methods for modulating interleukin-2-inducible t-cell kinase23 Jul 2026US 2026/0209216 A1Corvus Pharmaceuticals, Inc.
- Sulfoxide and sulfone glucokinase activators and methods of use thereof16 Jul 2026US 2026/0200881 A1vTv Therapeutics LLC
- Novel enantiomers of a series of antiviral compounds21 May 2026US 2026/0137669 A1Innovative Molecules GmbH
- Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions30 Apr 2026US 2026/0116875 A1Reglagene, Inc.
Most cited
By later US patents
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Thiazolidine derivatives138US 4,287,200 ATakeda Chemical Industries, Ltd. · 1981
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009
- Modulators of ATP-binding cassette transporters106US 7,977,322 B2Vertex Pharmaceuticals Incorporated · 2011
- Modulators of ATP-binding cassette transporters73US 8,541,453 B2Vertex Pharmaceuticals Incorporated · 2013